• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌伴肌肉减少症:一个值得关注的领域。

Gastric Cancer with Sarcopenia: an Area Worth Focusing On.

机构信息

Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, China.

National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.

出版信息

Curr Treat Options Oncol. 2023 Oct;24(10):1305-1327. doi: 10.1007/s11864-023-01122-y. Epub 2023 Jul 19.

DOI:10.1007/s11864-023-01122-y
PMID:37464229
Abstract

Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer death worldwide, which seriously endangers human health. A number of studies have shown that sarcopenia occurs more frequently in patients with gastric cancer than in the general population and can significantly affect the disease status and survival of patients, which is of great significance in predicting the prognosis of gastric cancer. Patients with gastric cancer may suffer sarcopenia no matter before or after surgery, and the pathogenesis is complex. Abnormal nutrient metabolism and reduced exercise are the leading causes. In addition, surgical treatment and chemotherapy for gastric cancer might participate in the physiological and pathological mechanism of sarcopenia. Generally speaking, exercise and nutritional therapy are the main prevention and treatment methods for sarcopenia. But more prospective evidence is needed to establish reasonable interventions, and other drug treatments are in their infancy. For the diagnostic criteria of sarcopenia, the cut-off values of the skeletal muscle mass index obtained from CT images vary widely and need to be standardized and unified. We also need to explore simple predictors to facilitate sarcopenia risk assessment. More research is needed to formulate more appropriate treatments for gastric cancer patients with sarcopenia.

摘要

胃癌(GC)是全球第五大常见癌症和第三大癌症死亡原因,严重危害人类健康。许多研究表明,胃癌患者比普通人群更容易发生肌肉减少症,并且可以显著影响患者的疾病状态和生存,这对于预测胃癌的预后具有重要意义。胃癌患者无论在手术前还是手术后都可能患有肌肉减少症,其发病机制复杂。异常的营养代谢和运动量减少是主要原因。此外,胃癌的手术治疗和化疗可能参与肌肉减少症的生理和病理机制。一般来说,运动和营养治疗是肌肉减少症的主要预防和治疗方法。但需要更多的前瞻性证据来建立合理的干预措施,其他药物治疗仍处于起步阶段。对于肌肉减少症的诊断标准,从 CT 图像获得的骨骼肌质量指数的截断值差异很大,需要标准化和统一。我们还需要探索简单的预测因子来方便肌肉减少症风险评估。需要进一步研究为患有肌肉减少症的胃癌患者制定更合适的治疗方法。

相似文献

1
Gastric Cancer with Sarcopenia: an Area Worth Focusing On.胃癌伴肌肉减少症:一个值得关注的领域。
Curr Treat Options Oncol. 2023 Oct;24(10):1305-1327. doi: 10.1007/s11864-023-01122-y. Epub 2023 Jul 19.
2
Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer.骨骼肌指数最佳截断值定义肌少症预测晚期胃癌患者生存的价值。
Ann Surg Oncol. 2018 Nov;25(12):3596-3603. doi: 10.1245/s10434-018-6728-7. Epub 2018 Aug 30.
3
Sarcopenia is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy.肌肉减少症与接受胃切除术的胃癌患者的围手术期结局相关。
Ann Nutr Metab. 2019;75(4):213-222. doi: 10.1159/000504283. Epub 2019 Dec 17.
4
Sarcopenia and Comorbidity in Gastric Cancer Surgery as a Useful Combined Factor to Predict Eventual Death from Other Causes.胃癌手术中的肌肉减少症和合并症作为一个有用的综合因素预测其他原因导致的最终死亡。
Ann Surg Oncol. 2018 May;25(5):1160-1166. doi: 10.1245/s10434-018-6354-4. Epub 2018 Feb 5.
5
Strong impact of sarcopenia as a risk factor of survival in resected gastric cancer patients: first Italian report of a Bicentric study.肌肉减少症作为胃癌患者术后生存的危险因素的强烈影响:一项来自两个中心的意大利研究的首次报告。
Updates Surg. 2022 Feb;74(1):283-293. doi: 10.1007/s13304-021-01175-4. Epub 2021 Oct 26.
6
Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer.CT 检测骨骼肌减少症对晚期胃癌患者预后的意义。
PLoS One. 2018 Aug 20;13(8):e0202700. doi: 10.1371/journal.pone.0202700. eCollection 2018.
7
Long-Term Outcomes of Gastric Cancer Patients with Preoperative Sarcopenia.术前肌肉减少症对胃癌患者长期预后的影响。
Ann Surg Oncol. 2018 Jun;25(6):1625-1632. doi: 10.1245/s10434-018-6452-3. Epub 2018 Apr 9.
8
Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer.肌肉减少症与接受食管癌和胃癌新辅助化疗患者的毒性反应相关。
Eur J Surg Oncol. 2015 Mar;41(3):333-8. doi: 10.1016/j.ejso.2014.11.040. Epub 2014 Nov 26.
9
Clinical Impact of Sarcopenia on Gastric Cancer.肌少症对胃癌的临床影响
Anticancer Res. 2019 May;39(5):2241-2249. doi: 10.21873/anticanres.13340.
10
Survival Impact of Postoperative Skeletal Muscle Loss in Gastric Cancer Patients Who Underwent Gastrectomy.接受胃切除术的胃癌患者术后骨骼肌丢失对生存的影响
Anticancer Res. 2023 Jan;43(1):223-230. doi: 10.21873/anticanres.16153.

引用本文的文献

1
RBPMS2 can inhibit the NLRP3 / caspase-1 / GSDMD signaling pathway to resist pyroptosis in gastric cancer cells.RBPMS2可抑制NLRP3/caspase-1/GSDMD信号通路,以抵抗胃癌细胞的焦亡。
Sci Rep. 2025 Jul 1;15(1):21294. doi: 10.1038/s41598-025-01125-9.
2
Effectiveness of home-based exercise combined with nutritional care intervention in elderly patients with gastric cancer and sarcopenia: a retrospective study.居家锻炼联合营养护理干预对老年胃癌合并肌少症患者的有效性:一项回顾性研究
Front Med (Lausanne). 2025 May 22;12:1544689. doi: 10.3389/fmed.2025.1544689. eCollection 2025.
3
Geriatric Nutrition Risk Index is closely associated with sarcopenia and quality of life in gastric cancer patients: a cross-sectional study.

本文引用的文献

1
Does neoadjuvant chemotherapy regimen affect sarcopenia status in patients with breast cancer?新辅助化疗方案是否会影响乳腺癌患者的肌肉减少症状态?
Breast. 2022 Dec;66:1-7. doi: 10.1016/j.breast.2022.08.009. Epub 2022 Aug 29.
2
5-Fluorouracil disrupts skeletal muscle immune cells and impairs skeletal muscle repair and remodeling.5-氟尿嘧啶会破坏骨骼肌免疫细胞,损害骨骼肌修复和重塑。
J Appl Physiol (1985). 2022 Oct 1;133(4):834-849. doi: 10.1152/japplphysiol.00325.2022. Epub 2022 Aug 25.
3
Benefit of laparoscopic compared to standard open gastric cancer surgery for sarcopenic patients: a propensity score-matching analysis.
老年营养风险指数与胃癌患者的肌肉减少症和生活质量密切相关:一项横断面研究。
Sci Rep. 2024 Dec 28;14(1):31545. doi: 10.1038/s41598-024-83380-w.
腹腔镜与标准开腹胃癌手术治疗肌肉减少症患者的疗效比较:倾向评分匹配分析。
Surg Endosc. 2022 Dec;36(12):9244-9253. doi: 10.1007/s00464-022-09416-2. Epub 2022 Jul 15.
4
Skeletal muscle adaptations to exercise are not influenced by metformin treatment in humans: secondary analyses of 2 randomized, clinical trials.骨骼肌对运动的适应不受二甲双胍治疗的影响:2 项随机临床试验的二次分析。
Appl Physiol Nutr Metab. 2022 Mar;47(3):309-320. doi: 10.1139/apnm-2021-0194. Epub 2021 Nov 16.
5
Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.基于氟尿嘧啶的不可切除胃癌患者一线姑息化疗中骨骼肌量的影响。
BMC Cancer. 2021 Nov 13;21(1):1219. doi: 10.1186/s12885-021-08953-8.
6
Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?激素变化对慢性肾脏病肌少症的影响:我们现在在哪里,我们能做些什么?
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1380-1392. doi: 10.1002/jcsm.12839. Epub 2021 Oct 21.
7
Prognostic significance of surgery-induced sarcopenia in the survival of gastric cancer patients: a sex-specific analysis.手术引起的肌肉减少症对胃癌患者生存的预后意义:性别特异性分析。
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1897-1907. doi: 10.1002/jcsm.12793. Epub 2021 Sep 17.
8
Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis.免疫检查点抑制剂治疗的实体瘤患者中肌肉减少症的预测影响:一项荟萃分析。
J Cachexia Sarcopenia Muscle. 2021 Oct;12(5):1122-1135. doi: 10.1002/jcsm.12755. Epub 2021 Aug 1.
9
AWGS2019 EWGSOP2 for diagnosing sarcopenia to predict long-term prognosis in Chinese patients with gastric cancer after radical gastrectomy.2019年亚洲肌少症工作组(AWGS2019)和欧洲老年人肌少症工作组(EWGSOP2)用于诊断肌少症以预测中国胃癌患者根治性胃切除术后的长期预后。
World J Clin Cases. 2021 Jun 26;9(18):4668-4680. doi: 10.12998/wjcc.v9.i18.4668.
10
The prevalence and the impact of sarcopenia in digestive cancers. A systematic review.肌肉减少症在消化系统癌症中的流行情况及其影响。系统综述。
Rom J Intern Med. 2021 Nov 20;59(4):328-344. doi: 10.2478/rjim-2021-0026. Print 2021 Dec 1.